In Sydney today, the Australian-Thai HIV Vaccine Consortium announced that recruitment of volunteers has begun for the first clinical trials of a new Australian-developed HIV vaccine. The trial, to take place at Sydney's St. Vincent's Hospital, will involve 24 HIV-negative volunteers. "We will be able to undertake a range of sophisticated laboratory tests to determine if the vaccines stimulate the human immune system to produce anti-HIV responses," said principal investigator Dr. Tony Kelleher of the University of New South Wales. The vaccine is based on "prime and boost" technology, which combines modified HIV DNA with a fowl pox virus. Results are expected by the end of the year. The trial is funded by a grant from the U.S. National Institutes of Health and the Australian government.
Back to other CDC news for June 4, 2003